ATLANTA, Dec. 4, 2025 /PRNewswire/ -- Today, NeuroVice announced that PATI is now commercially available, marking a breakthrough moment for millions of patients living with focal and grand-mal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results